Longtime Sanofi R&D chief Elias Zerhouni is on his way out, handing the research reins to Roche vet John Reed
After 7 years as head of Sanofi R&D, former NIH chief Elias Zerhouni is stepping down and handing the job to John Reed, who spent the last 5 years running Roche’s pRED research group based in Basel.
A spokesperson for Sanofi tells me that Reed, like Zerhouni, will have offices in Cambridge, MA and Paris.
The change at the top of the Paris-based pharma giant’s research arm marks the latest in a series of switch-ups in the world’s biggest pharma R&D organizations, with Hal Barron taking over at GlaxoSmithKline, Dan Skovronsky stepping up at Eli Lilly and John Tsai taking charge of development at Novartis.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.